Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 3: Melanoma Immunotherapy
Submit an article Journal homepage
1,380
Views
1
CrossRef citations to date
0
Altmetric
Melanoma Immunotherapy SF – Reviews

Neoadjuvant immune checkpoint inhibitors in high-risk stage III melanoma

Virginia FerraresiUOSD Sarcomas and Rare Tumors, IRCCS Regina Elena National Cancer Institute, Rome, ItalyCorrespondence[email protected]
&
Sabrina VariUOSD Sarcomas and Rare Tumors, IRCCS Regina Elena National Cancer Institute, Rome, Italy
Article: 1971015 | Received 18 May 2021, Accepted 15 Aug 2021, Published online: 09 Dec 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.